Images List Premium Download Classic

VER

VER-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Targeted nanocarriers for targeted drug delivery of gene therapeutics
Rodos Biotarget Gmbh
May 24, 2018 - N°20180140717

A targeted nanocarriers also termed nanomedicines and methods of preferentially, or actively, targeting and delivering a tool for gene transfer or genome editing (i.e., a plasmid or a restriction enzyme such as a zinc finger nuclease, a crispr/cas system, or a talen) or a tool for gene silencing or post-transcriptional regulation of gene expression (i.e., a microrna, ...
NEW Site-specific covalent chemical ligation to monoclonal and polyclonal immunoglobulin
The Regents Of The University Of California
May 24, 2018 - N°20180140715

Methods and compositions are described herein for covalently linking an antibody to a molecular payload. Compositions are described herein containing an antibody covalently linked to a molecular payload..
NEW N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
Nektar Therapeutics
May 24, 2018 - N°20180140712

The invention relates to (among other things) n-optionally substituted aryl-2-oligomer-3-alkoxypropionamides and compositions comprising the same. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer..
NEW VER Patent Pack
Download 342+ patent application PDFs
VER Patent Applications
Download 342+ VER-related PDFs
For professional research & prior art discovery
inventor
  • 342+ full patent PDF documents of VER-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Therapeutic mixture comprising an herbal compound
May 24, 2018 - N°20180140707

Disclosed is a method of preparing a therapeutic mixture including an herbal compound. Further, the method may include selecting, using a first selector unit, a cyclodextrin compound.
NEW Cured oil-hydrogel biomaterial compositions for controlled drug delivery
Atrium Medical Corporation
May 24, 2018 - N°20180140705

The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising na-cmc). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one ...
NEW Tumor radiosensitization with antibody conjugates
The Regents Of The University California
May 24, 2018 - N°20180140703

Disclosed herein, the invention pertains to methods and compositions that find use in radiosensitization of tumors and tumor samples based on the ability of a tumor sample to cleave a mts molecule of the present invention. The mts molecules of the present invention have a formula as disclosed herein and wherein a is a peptide with a sequence comprising 5 to 9 ...
NEW VER Patent Pack
Download 342+ patent application PDFs
VER Patent Applications
Download 342+ VER-related PDFs
For professional research & prior art discovery
inventor
  • 342+ full patent PDF documents of VER-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
University Of Leicester
May 24, 2018 - N°20180140697

The present invention relates to masp-3 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of masp-3 dependent complement activation.. .
NEW Adjuvant and vaccine compositions
Advanced Bioadjuvants, Llc
May 24, 2018 - N°20180140696

Methods are provided for preparing and delivering an adjuvant for vaccines including lecithin, polymer and one or more additives. The polymer is preferably polyacrylic acid-based.
NEW Group a streptococcus pharmaceutical compositions and methods thereof
University Of Wollongong
May 24, 2018 - N°20180140693

Isolated proteins and immunogenic fragments thereof, for use in the treatment and prevention of a group a streptococcus infection are provided. In particular, the invention provides pharmaceutical compositions and methods of prophylactic and/or therapeutic treatment of a group a streptococcus infection..
NEW Interferon-ß production modulating listeria strains and methods for using same
The Regents Of The University Of California
May 24, 2018 - N°20180140692

Mutant listeria bacteria that modulate interferon-β production are provided. The subject bacteria are characterized by having a mutation in a gene chosen from a tetr gene, a ladr gene, a virr gene, a marr gene a mdrl gene, a mdrt gene and a mdrm gene.
NEW Laser-assisted intradermal administration of active substances
Pantec Biosolutions Ag
May 24, 2018 - N°20180140690

A vaccine preparation comprising an antigen for use in the prophylactic or therapeutic treatment of a subject by intradermal administration through laser-generated micropores, wherein the antigen is linked to a binder of a dermal migratory antigen-presenting cell (apc); and a pharmaceutical preparation comprising an active substance for use in the prophylactic or therapeutic treatment of a subject by intradermal administration ...
NEW Humanized antibodies
Probiodrug Ag
May 24, 2018 - N°20180140689

The invention relates to humanized antibodies that bind to an epitope at the n-terminus of pyroglutamated amyloid beta (aβ n3pe) peptide and to preventive and therapeutic treatment of diseases and conditions that are related to accumulation and deposition of amyloid peptides, such as amyloidosis, a group of disorders and abnormalities associated with pyroglutamated amyloid peptide, like alzheimer's ...
NEW Propionyl-coa carboxylase compositions and uses thereof
The Regents Of The University Of Colorado, A Body Corporate
May 24, 2018 - N°20180140688

This invention provides compositions of human propionyl-coa carboxylase (pcc) and pharmaceutical compositons of human pcc and methods for treating conditions such as propionic acidemia (pa), propionic aciduria, propionyl-coa carboxylase deficiency and ketotic glycinemia.. .
NEW VER Patent Pack
Download 342+ patent application PDFs
VER Patent Applications
Download 342+ VER-related PDFs
For professional research & prior art discovery
inventor
  • 342+ full patent PDF documents of VER-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Enzymatic immunomodulation of solid tumors and uses thereof
University Of Houston System
May 24, 2018 - N°20180140686

In some embodiments the present disclosure pertains to a method of activating an anti-tumor immune response for the treatment of a cancer. In some embodiments, such a method comprises detecting cd26 expression in a subject in need thereof.
NEW Modulation of muscle and adipocyte distribution and fate
The Board Of Trustees Of The Leland Stanford Junior University
May 24, 2018 - N°20180140684

Modulation of the adamts1 signaling pathway alters the commitment of progenitor cells to a muscle fate; and increases muscle mass.. .
NEW Gene editing methods and compositions for eliminating risk of jc virus activation and pml (progressive ...
Temple University Of The Commonwealth System Of Higher Education
May 24, 2018 - N°20180140682

A method of eliminating the risk of jcv activation in a subject undergoing immunosuppressive therapy, by administering an effective amount of a gene editing composition directed toward at least one target sequence in the jcv genome, cleaving the target sequence in the jcv genome, disrupting the jcv genome, eliminating the jcv infection, eliminating the risk of jcv activation, and treating ...
NEW Composition for preventing or treating autoimmune disease, containing ssu72 as active ingredient
The Catholic University Of Korea Industry- Academic Cooperation Foundation
May 24, 2018 - N°20180140681

The present disclosure relates to a composition for preventing or treating an autoimmune disease, in which the composition includes ssu72 as an active ingredient. According to the present invention, ssu72 has an effect of effectively inhibiting stat3 activity, thereby effectively preventing and treating, ultimately, an immune disease, and preferably, stat3-mediated diseases through an action capable of inhibiting the expression ...
NEW Nanoreactor using polyion complex polymersomes, and method for producing same
The University Of Tokyo
May 24, 2018 - N°20180140680

The present invention provides a nanoreactor (nano size reaction field) using a polyion complex polymersome and a method for producing the nanoreactor. The present invention provides a polyion complex polymersome encapsulating e.g., an enzyme, in which the enzyme is an enzyme acting on a substance passing through a membrane of the polyion complex polymersome, as a substrate..
NEW Modulation of axl receptor activity in combination with cytoreductive therapy
The Board Of Trustees Of The Leland Stanford Junior University
May 24, 2018 - N°20180140679

Compositions and methods are provided for treating cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits axl protein activity, for example by inhibition of the binding interaction between axl and its ligand gas6. The treatment may be combined with a cytoreductive therapy..
NEW Directed stem cell recruitment
Wake Forest University Health Sciences
May 24, 2018 - N°20180140678

The invention is directed to methods of inducing cell recruitment and tissue regeneration at a target site in a subject. It is also based, in part, on the discovery that a subject's own biologic resources and environmental conditions can be used for in situ tissue regeneration and thereby reduce or eliminate the need for donor cell procurement and ex vivo ...
NEW Enhanced melanoma cancer prevention by novel melanotropins
The Arizona Board Of Regents On Behalf Of The University Of Arizona
May 24, 2018 - N°20180140677

A gamma-melanocyte stimulating hormone (γ-msh) derivative having improved stability, selectivity and bioavailabilty. The γ-msh derivative is selective for the melanocortin-1 receptor (mc1 r) and is deliverable to skin cells via topical or transdermal delivery.
Loading